Abstract
We describe a patient who developed dilated cardiomyopathy and clinical congestive heart failure after 2 months of therapy with amphotericin B (AmB) for disseminated coccidioidomycosis. His echocardiographic abnormalities and heart failure resolved after posaconazole was substituted for AmB. It is important to recognize the rare and potentially reversible toxicity of AmB.
Author supplied keywords
Cite
CITATION STYLE
APA
Danaher, P. J., Cao, M. K., Anstead, G. M., Dolan, M. J., & DeWitt, C. C. (2004). Reversible dilated cardiomyopathy related to amphotericin B therapy. Journal of Antimicrobial Chemotherapy, 53(1), 115–117. https://doi.org/10.1093/jac/dkg472
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free